NB
BIIB icon

Northwest Bancshares’s Biogen BIIB Stock Holding History

Northwest Bancshares’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-13,509
Closed -$3.31M – 235
2020
Q4 		$3.31M Buy
13,509
+2,246
+20% +$579K 0.85% 46
2020
Q3 		$3.19M Buy
11,263
+177
+2% +$49.4K 0.83% 44
2020
Q2 		$2.97M Buy
11,086
+200
+2% +$60.1K 0.81% 44
2020
Q1 		$3.44M Buy
10,886
+334
+3% +$101K 1.71% 15
2019
Q4 		$3.13M Sell
10,552
-457
-4% -$127K 1.21% 37
2019
Q3 		$2.56M Buy
11,009
+377
+4% +$87.8K 1.06% 48
2019
Q2 		$2.49M Buy
10,632
+2,404
+29% +$555K 1.05% 47
2019
Q1 		$1.95M Buy
8,228
+1,179
+17% +$371K 0.84% 47
2018
Q4 		$2.12M Buy
7,049
+1,755
+33% +$560K 1.02% 38
2018
Q3 		$1.87M Buy
5,294
+297
+6% +$102K 0.83% 36
2018
Q2 		$1.45M Buy
4,997
+253
+5% +$71.1K 0.61% 44
2018
Q1 		$1.3M Buy
4,744
+359
+8% +$111K 0.53% 56
2017
Q4 		$1.4M Buy
+4,385
New +$1.41M 0.57% 56

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Northwest Bancshares's BIIB Position: Q1 2021 in Review

Northwest Bancshares sold out of Biogen (BIIB) in Q1 2021, closing a stake of 13,509 shares — an estimated $3.31M sold.

Northwest Bancshares first reported a position in BIIB in Q4 2017 and held it in 13 quarters. The position peaked at $3.44M in Q1 2020. 1,093 funds tracked by Wall St. Rank hold BIIB as of Q1 2021.

  • Northwest Bancshares reported no remaining Biogen position as of Q1 2021 after selling out during the quarter.
  • Northwest Bancshares sold 13,509 Biogen shares in Q1 2021, an estimated $3.31M.
  • Northwest Bancshares first reported a position in Biogen in Q4 2017 and held it in 13 quarters.
  • Northwest Bancshares's Biogen position peaked at $3.44M in Q1 2020.
  • 1,093 funds tracked by Wall St. Rank held Biogen as of Q1 2021.

Based on Northwest Bancshares's 13F filing for Q1 2021, filed 23 Apr 2021.